Armistice Capital »

AtriCure shares owned by Armistice Capital

Quarter-by-quarter ownership of AtriCure (ATRC) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in AtriCure

Tip: Access up to 7 years of quarterly data

All positions including AtriCure held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AtriCure by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.2M 28k 43.80
2023-03-31 $245k 5.9k 41.45

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding AtriCure

Vanguard Group
Alliancebernstein
First Light Asset Management
Wellington Management Company
Fred Alger Management
Dimensional Fund Advisors
Credit Suisse
TimesSquare Capital Management
Fiera Capital Corporation
Bellevue Group
Jennifer Ranahan
Neuberger Berman Group
Daniel D. Thurber
Millennium Management
Bnp Paribas Investment Partners

View all funds holding AtriCure